| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd740dcf2893f1a13c4bc4763e25e9ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ede649a3f5047f79f31ec4bec1a3afe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c91c20abe174d6f60fb9251fff592188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f3e2b92bce71ff989c89bbae0544c5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07ba5e7ff356b7eda43fdfc20eef4b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7063714bae882672b26a1718fbc4514e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4723 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2002-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0b187f12e580d47549c0eaf88ca11e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c21bc39ba10eab7b5816420bda00dc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d58e21e7a642e336cd06dd78b050219
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59ba25fa6f9cab93d0350bd269589aef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50880dfeaed6a9d483bb728cd1e904ab |
| publicationDate |
2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03024992-A2 |
| titleOfInvention |
HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES |
| abstract |
The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 β-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the β-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents antibiotics. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007007116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7563767-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004063219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016520052-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004203966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9822155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2639559-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2994481-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109957551-A |
| priorityDate |
2001-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |